Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.
about
Diverse hematological malignancies including hodgkin-like lymphomas develop in chimeric MHC class II transgenic mice.Cancer gene discovery in mouse and man.Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia.Impairment of alternative splice sites defining a novel gammaretroviral exon within gag modifies the oncogenic properties of Akv murine leukemia virus.Animal models of acute myelogenous leukaemia - development, application and future perspectives.Predicting preferential DNA vector insertion sites: implications for functional genomics and gene therapy.Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy.Large-scale identification of disease genes involved in acute myeloid leukemiaMutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.Activation of clg, a novel dbl family guanine nucleotide exchange factor gene, by proviral insertion at evi24, a common integration site in B cell and myeloid leukemias.Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002.Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging.
P2860
Q33521713-6884903B-F6EA-470E-BB14-30C596B73972Q34962407-0A06471F-0FDB-4E2D-B154-B0FC856D0FF9Q35186888-01FE0BBD-D70F-41CC-8D2A-177883296764Q35919339-D2FAB741-1B40-4B20-85B8-29F7794545FBQ36066980-F925D07D-1B85-4EED-8CC3-9A1A97101C85Q36187534-D288F207-88ED-48D8-9186-5E975D9FF4F5Q36698269-A226ADEC-0B92-4D10-AE55-EE3577B267FCQ36959992-06CD5FFE-2FEA-45A8-BD06-E96F5E6C2F71Q37596450-CB32E242-501B-4EE5-AB8C-EE54D9316EC8Q39403641-0E4923FB-1174-4D90-913B-65AAF3FFBEA3Q42818782-AA6AA66D-3F09-4496-82F4-123C4EC64DCBQ44619783-9C144CAF-D0A0-4F9D-B445-C64623A6FFC4Q45735381-784B02FF-29E6-48EE-8C8B-EBD7826B5B0B
P2860
Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Genetic heterogeneity in acute ...... from MuLV mutagenesis studies.
@ast
Genetic heterogeneity in acute ...... from MuLV mutagenesis studies.
@en
type
label
Genetic heterogeneity in acute ...... from MuLV mutagenesis studies.
@ast
Genetic heterogeneity in acute ...... from MuLV mutagenesis studies.
@en
prefLabel
Genetic heterogeneity in acute ...... from MuLV mutagenesis studies.
@ast
Genetic heterogeneity in acute ...... from MuLV mutagenesis studies.
@en
P356
P1433
P1476
Genetic heterogeneity in acute ...... from MuLV mutagenesis studies.
@en
P2093
Largaespada DA
P2888
P304
P356
10.1038/SJ.LEU.2401852
P577
2000-07-01T00:00:00Z
P5875
P6179
1019309085